How long should a patient stop the combined oral contraceptive before undergoing a cosyntropin (ACTH‑stimulation) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Duration to Stop Oral Contraceptives Before Cosyntropin Testing

Stop combined oral contraceptives 4-6 weeks before performing a cosyntropin (ACTH stimulation) test, with emerging evidence suggesting 4 weeks may be sufficient.

Rationale and Evidence

The primary concern with oral contraceptives (OCPs) during cosyntropin testing stems from estrogen's effect on cortisol-binding globulin (CBG). Estrogens increase CBG concentrations in circulation, which elevates total serum cortisol measurements—the standard endpoint for cosyntropin testing. This creates a significant risk of false-positive results that could mask true adrenal insufficiency.

FDA-Approved Drug Label Guidance

The FDA-approved cosyntropin drug label explicitly states: "Stop estrogen-containing drugs four to six weeks before cosyntropin for injection testing" 1. This represents the official prescribing guidance and should be considered the standard of care.

Supporting Guideline Evidence

The 2008 Endocrine Society Clinical Practice Guideline on Cushing's syndrome diagnosis reinforces this recommendation, noting that false-positive rates for dexamethasone suppression tests occur in 50% of women taking oral contraceptive pills due to increased CBG levels 2. The guideline specifically states: "Wherever possible, estrogen-containing drugs should be withdrawn for 6 wk before testing or retesting" 2.

Similarly, a 2016 consensus on primary aldosteronism recommends that "spironolactone, diuretics and oral contraceptives should be interrupted 4-6 weeks ahead of examination" for functional imaging studies that also measure cortisol 3.

Recent Research Refining the Timeline

A 2026 prospective study provides the most current evidence on this question 4. This study directly measured CBG and total cortisol concentrations in 24 healthy women after stopping combined oral contraceptives, with weekly measurements for 6 weeks. The findings showed:

  • CBG decreased from 133 mg/L at baseline to 59 mg/L at 6 weeks
  • Total cortisol decreased from 855 nmol/L to 370 nmol/L at 6 weeks
  • Both CBG and cortisol showed an immediate exponential decrease after OCP cessation
  • By 4 weeks, concentrations had reached approximately 49% of baseline for CBG and 46% for total cortisol
  • Statistical modeling showed non-significant changes after 4 weeks

The authors concluded that the minimum discontinuation period could potentially be reduced from 6 weeks to 4 weeks 4.

Clinical Algorithm

Standard Approach:

  1. Discontinue estrogen-containing oral contraceptives 4-6 weeks before cosyntropin testing
  2. Document the exact date of OCP discontinuation
  3. Ensure at least 4 weeks have elapsed before proceeding with testing
  4. If testing is urgent and cannot wait, consider alternative approaches (see below)

Important Caveats:

Drug interactions to address on test day:

  • Stop glucocorticoids on the day of testing (though long-acting formulations may require longer discontinuation) 1
  • Stop spironolactone on the day of testing 1

When OCP discontinuation is not feasible: Recent research suggests salivary cortisol or cortisone measurements may circumvent the CBG confounding effect. A 2024 study found that salivary cortisone during cosyntropin testing was minimally affected by OCP use, with similar lower reference limits between OCP users and non-users 5. However, this approach requires specialized laboratory capabilities and is not yet standard practice.

Common Pitfalls to Avoid

  1. Don't assume all hormonal contraceptives require discontinuation: Only estrogen-containing products significantly affect CBG. Progestin-only contraceptives do not require discontinuation.

  2. Don't forget about other estrogen sources: Hormone replacement therapy, transdermal estrogen patches, and vaginal estrogen rings also increase CBG and require similar discontinuation periods.

  3. Don't interpret results without knowing medication history: If a patient underwent testing while on OCPs, results showing "normal" cortisol responses may be falsely reassuring and mask true adrenal insufficiency.

  4. Don't use the same cortisol cutoffs: If testing must proceed without adequate OCP discontinuation, recognize that standard diagnostic thresholds (typically <18 mcg/dL or 500 nmol/L at 30-60 minutes) may not apply 6, 1.

Practical Considerations

For patients with suspected adrenal insufficiency who are on OCPs, the 4-6 week waiting period is justified to ensure accurate diagnosis, as missing true adrenal insufficiency carries significant morbidity and mortality risk. The conservative 6-week recommendation from FDA labeling remains the safest approach 1, though emerging evidence supports 4 weeks as potentially adequate 4.

In emergency situations where adrenal crisis is suspected, immediate treatment with stress-dose hydrocortisone should not be delayed for proper test preparation 6.

References

2
Guideline

the diagnosis of cushing's syndrome: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2008

Related Questions

How long must glucocorticoid steroids be discontinued before serum cortisol testing?
How long does it take for serum hormone levels to normalize after stopping estradiol therapy?
What are the Spanish instructions for conducting an ACTH stimulation test to evaluate cortisol response?
What should a patient being evaluated for adrenal insufficiency do or avoid in the two weeks before cortisol, aldosterone, and renin testing to ensure accurate results?
Should I wait for the ACTH (Synacthen) stimulation test before starting glucocorticoid therapy in a female patient with an 8 AM serum cortisol of 16.07 µg/dL?
Can a patient with bipolar disorder and a history of psychotic features who is receiving an intramuscular antipsychotic also be treated with a mood stabilizer such as lithium?
Are there any concerns with taking Wellbutrin (bupropion) while smoking cigarettes?
How should pain be managed in a 23-year-old male with left lumbar pain, penile pain, and difficulty urinating for 3–4 hours, who has non‑obstructive bilateral renal calculi on ultrasound performed three months ago?
For a 76‑year‑old patient with type 2 diabetes mellitus on metformin 1000 mg daily and an HbA1c of 6.8 %, should the current regimen be continued or adjusted?
How should I adjust the regimen for a patient with elevated blood pressure who is already taking lisinopril 20 mg daily, furosemide (Lasix) 20 mg daily, metoprolol extended‑release 12.5 mg daily, amiodarone 100 mg daily, and hydralazine 25 mg twice daily?
In a patient with an estimated glomerular filtration rate of 46.6 mL/min/1.73 m² (stage 3 chronic kidney disease) who is taking lisinopril 20 mg daily, furosemide 20 mg daily, metoprolol extended‑release 12.5 mg daily, and hydralazine 25 mg twice daily, how should these medications be managed or adjusted?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.